Bookmark

Add to MyYahoo RSS

Rosetta Genomics News

News on Rosetta Genomics (Ticker: ROSG) continually updated from thousands of sources around the net.

Thursday Jul 31 | MacReport Media RSS Feed

Rosetta Genomics Announces Agreement With Global Pharmaceutical...

Leverages Rosetta's microRNA Biomarker Platform and Expertise and Global Pharmaceutical Company's Expertise in Alzheimer's Biology and Drug Development to Develop a Diagnostic for the Early Detection of Alzheimer's Disease ), a leading developer and provider of microRNA-based molecular diagnostics, announces that it has signed an agreement with a ... (more)

Comment?

Related Topix: Biotech, Alzheimer's, Health

Tue Jul 29, 2014

MacReport Media RSS Feed

Rosetta Genomics Announces Next-Generation Sequencing Research...

Ltd., the commercial arm of the Weizmann Institute of Science. The agreement involves collaboration with the Nancy and Stephen Grand Israel National Center for Personalized Medicine to develop novel methods for the preparation of next-generation sequencing libraries for small RNAs.

Comment?

Related Topix: Biotech, Health, Mesothelioma

Tue Jul 22, 2014

Sys-Con Media

Rosetta Genomics Receives Final New York State Approval for Rosetta Kidney Cancer Test

PRINCETON, NJ and REHOVOT, ISRAEL-- - Rosetta Genomics Ltd. , a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, announced that the New York State Department of Health has given the Company final approval for its Rosetta Kidney Cancer Test for testing on patient samples from the State.

Comment?

Related Topix: Kidney Cancer, Health, Biotech, Princeton, NJ, Oncology, Medicine

Benzinga

Rosetta Genomics Announces Final New York State Approval for Rosetta Kidney Cancer Test

Rosetta Genomics Ltd. , a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, announced that the New York State Department of Health has given the Company final approval for its Rosetta Kidney Cancer Testa - for testing on patient samples from the State.

Comment?

Related Topix: Kidney Cancer, Health, Biotech, New York Government, New York

Thu Jul 10, 2014

MacReport Media RSS Feed

Rosetta Genomics Receives Notice of Allowance for U.S. Patent for the Treatment of Ovarian Cancer

AQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, announces receipt of a Notice of Allowance from the United States Patent and Trademark Office for U.S. Treatment for advanced ovarian carcinoma is typically based on the combination of surgery and chemotherapy.

Comment?

Related Topix: Ovarian Cancer, Health, Biotech, Patent / Trademark Law, Law, USPTO, Oncology, Medicine

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••